Rima Chakrabarti, M.D.

Rima is a partner at KdT Ventures where she invests in early-stage biotech spanning human health, climate technology, and synthetic biology. She sits on the boards of multiple companies including Dimension Inx, Cypris Materials, and Modulus Therapeutics. Prior to KdT, she directed the preclinical and clinical development of a portfolio of therapeutic assets at the Fannin Innovation Studio, a venture creation firm focused on technology commercialization in the life sciences.

Rima started her career as a neurologist at the University of Pennsylvania and is a physician-scientist trained at the University of Texas Southwestern Medical Center. Her research as a Howard Hughes Medical Institute fellow in the lab of Dr. Helen Hobbs focused on the development of bio-engineered assays to study lipid transport and metabolism in the context of cardiovascular disease.